Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?

MeSH terms

• Aged, 80 and over
• Antineoplastic Agents / therapeutic use
• Benzamides
• Dasatinib
• Female
• Flow Cytometry
• Genome, Human*
• Humans
• Imatinib Mesylate
• Immunophenotyping
• In Situ Hybridization, Fluorescence
• Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
• Leukemia, Lymphocytic, Chronic, B-Cell / pathology
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
• Lymphoid Progenitor Cells*
• Myeloid Progenitor Cells*
• Neoplasms, Second Primary / diagnosis*
• Neoplasms, Second Primary / drug therapy
• Neoplasms, Second Primary / genetics*
• Neoplasms, Second Primary / pathology
• Neoplastic Stem Cells*
• Piperazines / therapeutic use
• Pyrimidines / therapeutic use
• Thiazoles / therapeutic use